2 results match your criteria: "Department of Surgery University of Virginia Charlottesville VA.[Affiliation]"

Article Synopsis
  • Adults undergoing heart surgery are at high risk for respiratory complications, including COVID-19, but being fully vaccinated can help reduce this risk.
  • This study evaluated the impact of cardiopulmonary bypass (CPB) on COVID-19 antibody levels in 77 patients who had surgery; it found that antibody concentrations significantly dropped immediately after surgery but returned to pre-surgery levels within a month.
  • The research highlights the importance of monitoring COVID-19 vaccination status in cardiac surgery patients, as there was one reported case of COVID-19 pneumonia that resulted in death, emphasizing the need for enhanced safety measures during and after surgery.
View Article and Find Full Text PDF

Background We previously demonstrated that ischemically injured cardiomyocytes release cell-free DNA and HMGB1 (high mobility group box 1 protein) into circulation during reperfusion, activating proinflammatory responses and ultimately exacerbating reperfusion injury. We hypothesize that cell-free DNA and HMGB1 mediate myocardial ischemia-reperfusion injury by stimulating plasmacytoid dendritic cells (pDCs) to secrete type I interferon (IFN-I). Methods and Results C57BL/6 and interferon alpha receptor-1 knockout mice underwent 40 minutes of left coronary artery occlusion followed by 60 minutes of reperfusion (40'/60' IR) before infarct size was evaluated by 2,3,5-Triphenyltetrazolium chloride-Blue staining.

View Article and Find Full Text PDF